Cytek Biosciences, Inc.
CTKBNASDAQHealthcare● Active
$4.04
$-0.05(-1.22%)
Market Cap$521736051
P/E Ratio—
52W High$6.18
52W Low$2.9
Cytek Biosciences, Inc.（CTKB）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CTKB · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.07B) | ($0.01B) | ($0.01B) | $0.00B | $0.00B |
| Depreciation & Amort. | $0.01B | $0.01B | $0.01B | $0.01B | $0.00B |
| Stock-Based Comp. | $0.02B | $0.03B | $0.02B | $0.02B | $0.01B |
| Change in Working Capital | ($0.00B) | $0.01B | ($0.01B) | ($0.04B) | ($0.01B) |
| Net Cash from Operations | ($0.00B) | $0.03B | $0.01B | ($0.01B) | $0.00B |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.01B) | ($0.00B) |
| Purchases of Investments | ($0.28B) | ($0.27B) | ($0.18B) | ($0.05B) | $0.00B |
| Sales of Investments | $0.29B | $0.20B | $0.13B | $0.00B | $0.00B |
| Net Cash from Investing | $0.01B | ($0.08B) | ($0.09B) | ($0.06B) | ($0.02B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.02B) | ($0.02B) | ($0.04B) | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | ($0.00B) | $0.00B | ($0.00B) |
| Net Cash from Financing | ($0.01B) | ($0.02B) | ($0.04B) | $0.01B | $0.21B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.01B) | $0.02B | $0.00B | ($0.02B) | $0.00B |
| FCF Margin %(computed) | -4.35% | 10.90% | 0.24% | -13.47% | 0.21% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Cytek Biosciences, Inc.
关于Cytek Biosciences, Inc.（CTKB）现金流量表
Cytek Biosciences, Inc. 2025财年经营活动现金流($0.00B)，自由现金流($0.01B)（FCF利润率-4.35%），资本支出($0.00B)。
常见问题
CTKB · 4 问Cytek Biosciences, Inc. 2025财年自由现金流($0.01B)，同比down140.1%。
CTKB free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10